Showing results (71-80 of 110) with videos related to
Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2008
Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory GroupNicole Blijlevens, Matthias Schwenkglenks, Pamela Bacon, et al.Haematologica|October 14, 2011
CD34(+)/CD38(-) stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab/ozogamicinHarald Herrmann, Sabine Cerny-Reiterer, Karoline V Gleixner, et al.Experimental Hematology|June 18, 2010
In vitro and in vivo growth-inhibitory effects of cladribine on neoplastic mast cells exhibiting the imatinib-resistant KIT mutation D816VAlexandra Böhm, Karoline Sonneck, Karoline V Gleixner, et al.Anti-Cancer Drugs|January 19, 2005
Single-agent trastuzumab versus trastuzumab plus cytotoxic chemotherapy in metastatic breast cancer: a single-institution experienceWolfgang J Köstler, Günther G Steger, Michael Krainer, et al.The Journal of Investigative Dermatology|April 6, 2020
Anti-Apoptotic Molecule BCL2 Is a Therapeutic Target in Steroid-Refractory Graft-Versus-Host DiseaseJohanna Strobl, Ram Vinay Pandey, Thomas Krausgruber, et al.Vaccines|August 28, 2021
Tick-Borne Encephalitis Specific Lymphocyte Response after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Humoral Immunity after VaccinationNicole Harrison, Katharina Grabmeier-Pfistershammer, Alexandra Graf, et al.Anesthesiology|September 29, 2006
Airway management with endotracheal tube versus Combitube during parabolic flightsWerner Rabitsch, Doris Moser, Michelle R Inzunza, et al.The British Journal of Dermatology|November 27, 2023
Diverse macrophage populations contribute to distinct manifestations of human cutaneous graft-versus-host diseaseJohanna Strobl, Laura M Gail, Laura Krecu, et al.Journal of Cancer Research and Clinical Oncology|May 3, 2005
The efficacy of trastuzumab in Her-2/neu-overexpressing metastatic breast cancer is independent of p53 statusWolfgang J Köstler, Thomas Brodowicz, Gernot Hudelist, et al.Science Translational Medicine|November 19, 2020
Long-term skin-resident memory T cells proliferate in situ and are involved in human graft-versus-host diseaseJohanna Strobl, Ram Vinay Pandey, Thomas Krausgruber, et al.Pageof 11